COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 1549: Articles 15481-15490  | Next

Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials
H. Talasaz, A. H., Sadeghipour, P., Aghakouchakzadeh, M., Dreyfus, I., Kakavand, H., Ariannejad, H., Gupta, A., Madhavan, M., Van tassell, B., Jimenez, D., Monreal, M., Vaduganathan, M., Fanikos, J., Dixon, D., Piazza, G., Parikh, S., Bhatt, D., Lip, G., Stone, G., Krumholz, H., Libby, P., Goldhaber, S., Bikdeli, B.
10.1101/2021.05.03.21256468 — Posted: 2021-05-05
Prevalence use of nonsteroidal anti-inflammatory drugs in the general population with COVID-19 and associated COVID-19 risk, hospitalization, severity, death, and safety outcomes: A systematic review and meta-analysis
zhao, h., huang, s., mei, k., shao, w., jiang, y., zhu, w., ma, j., zhang, j., yu, p., liu, x.
10.1101/2021.05.01.21256428 — Posted: 2021-05-05
Smart Testing with Vaccination: A Bandit Algorithm for Active Sampling for Managing COVID-19
Wang, Y., Yahav, I., Padmanabhan, B.
10.1101/2021.05.01.21256469 — Posted: 2021-05-05
SARS-CoV-2 Seroprevalence and Risk Factors among Convalescents in Sichuan Province, China: a retrospective cohort study
Zhou, L., Li, C., Yang, H., Yuan, H., Pan, M., Cheng, X., Su, X., Zhu, Y., Xu, J., Tang, J., Du, X., Peng, H., Xiao, C., Huang, T., Xian, D., Liao, H., Wang, H., Liu, W., Zhou, P., Zhang, Z., Liu, J., Wu, X., Zhang, T.
10.1101/2021.05.04.21256355 — Posted: 2021-05-05
LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
Temesgen, Z., Burger, C. D., Baker, J., Polk, C., Libertin, C., Kelley, C., Marconi, V. C., Orenstein, R., Durrant, C., Chappell, D., Ahmed, O., Chappell, G., Badley, A.
10.1101/2021.05.01.21256470 — Posted: 2021-05-05
Prevalence of anxiety, depression, and stress among teachers during the COVID-19 pandemic: Systematic review
Silva, D. F. d. O., Cobucci, R. N. O., Lima, S. C. V. C., Andrade, F. B. d.
10.1101/2021.05.01.21256442 — Posted: 2021-05-05
Effect of commuting on the risk of COVID-19 and COVID-19-induced anxiety
Ando, H., Ikegami, K., Nagata, T., Tateishi, S., Eguchi, H., Tsuji, M., Matsuda, S., Fujino, Y., Ogami, A., the CORoNaWork project
10.1101/2021.05.01.21256090 — Posted: 2021-05-05
Population Vaccine Effectiveness and its Implication for Control of the Spread of COVID-19 in the US
Hu, Z., Ge, Q., Luo, L., Xu, T., Zhang, K., Lu, H. H., Lin, W., Boerwinkle, E., Jin, L., Xiong, M.
10.1101/2021.04.30.21256228 — Posted: 2021-05-05
Immunolocalization studies of vimentin and ACE2 on the surface of cells exposed to SARS-CoV-2 Spike proteins
Lalioti, V., Gonzalez-Sanz, S., Lois-Bermejo, I., Gonzalez-Jimenez, P., Viedma-Poyatos, A., Merino, A., Pajares, M. A., Perez-Sala, D.
10.1101/2021.05.04.442648 — Posted: 2021-05-04
Disordered eating and self-harm as risk factors for poorer mental health during the COVID-19 pandemic: A population-based cohort study
Warne, N., Heron, J., Mars, B., Kwong, A. S. F., Solmi, F., Pearson, R., Moran, P., Bould, H.
10.1101/2021.04.30.21256377 — Posted: 2021-05-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).